๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Babesiosis in a patient on infliximab for Crohn's disease

โœ Scribed by Garret Cullen; Bruce E. Sands; Vijay Yajnik


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
86 KB
Volume
16
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Salmonella septic arthritis in a patient
โœ Jean Y. Rim; Allan R. Tenorio ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 56 KB ๐Ÿ‘ 2 views

The use of tumor necrosis factor a (TNFa) inhibitors such as infliximab, etanercept, and adalimumab for various autoimmune diseases, including Crohn's disease (CD) and ulcerative colitis (UC), has increased in the past few years. While associated with symptomatic relief in many patients, the use of

Splenic tuberculosis in a patient with C
โœ Maria Cappello; Claudia Randazzo; Giulia Rizzuto; Celestino Bonura; Gaetano Di V ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 255 KB ๐Ÿ‘ 1 views

FIGURE 1. MRI of the spleen. a: T1-weighted image on dynamic contrast-enhancement (axial). b: T1-weighted image on dynamic contrast-enhancement (coronal).